Lawmakers concerned international drug manufacturing presents risk of counterfeits
New York Concern has arisen about the manufacturing of ingredients for drugs in other countries, especially antibiotics like penicillin, according to published reports.
Drug manufacturing has mostly moved to countries such as India and China, but some lawmakers and analysts have said it increases the risks of counterfeits and bioterrorism.Already, more than 200 Americans have experienced dangerous drug reactions since November 2007 after taking counterfeit versions of the blood-thinning drug heparin manufactured in China containing a toxic chemical that merely mimics heparin. Last November, the Food and Drug Administration confiscated 11 lots of counterfeit heparin from a company based in Cincinnati.
NIH funding chronic kidney disease research
Bethesda,, Md. The National Institutes of Health has announced that it will give up to $12.5 million to research projects looking for biomarkers for chronic kidney disease.
The National Institute of Diabetes and Digestive Kidney Diseases will disburse the money over a five-year period to fund collaborative projects, including $2.5 million this year.
RediClinic accepts Blue Shield of Texas in Austin clinics
Houston RediClinic has announced the expansion of an existing provider relationship under which the in-store clinics will now accept Blue Cross Blue Shield of Texas at its six Austin HEB locations.
With this expansion, all 21 Houston and Austin RediClinic locations now accept Blue Cross Blue Shield of Texas.For the patients not covered by Blue Cross Blue Shield of Texas, the clinic operator also accepts several other insurance plans including Aetna, Cigna, Humana and UnitedHealthcare.